NHS England

#Biomanufacturing #Fujifilm #NHS England #UK government

UK Chancellor hails FUJIFILM’s biomanufacturing expansion 

UK chancellor Rachel Reeves has hailed the expansion of FUJIFILM Biotechnologies facilities as “a vote of confidence in the UK”.  The Japanese company has expanded its facilities in the North East of England to support the biomanufacturing of innovative medicines and vaccines.  The company’s expanded… Read More

#News

Subcutaneous injection
#Bristol Myers Squibb #Immunotherapy #NHS England #Oncology

NHS England rolls out injectable immunotherapy for 15 cancers

NHS England has become the first national health service in Europe to offer Bristol Myers Squibb’s injectable cancer immunotherapy nivolumab (Opdivo).  Nivolumab is a monoclonal antibody that binds to PD-1 (programmed death-1) on T-cells.  The jab can be used to treat 15 cancer types, including… Read More

#News

Asthma inhaler
#Asthma #AstraZeneca #Clinical trial #National Institute for Health and Care Excellence (NICE) #NHS England

Add-on treatment for severe uncontrolled asthma approved 

The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending AstraZeneca’s Tezspire (tezepelumab).  The drug is approved for use within NHS England and NHS Wales and as add-on maintenance therapy in adult and adolescent patients, 12 years and older, with severe asthma… Read More

#News

Growing bacteria to create CAR therapy
#Cancer research #CAR-T #Immuno-oncology #Immunotherapy #Kite Pharma #National Institute for Health and Care Excellence (NICE) #NHS England #Oncology #UK

Ground-breaking CAR-T therapy approved in UK

Hundreds of people with an aggressive form of lymphoma are set to benefit from the first personalised immunotherapy treatment to be recommended for routine use in the NHS.  Axicabtagene ciloleucel (Yescarta, Kite) is a CAR-T therapy for adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL)… Read More

#News #Regulatory #Trending News